1.
Topic:Integrated Branding Management in State-owned Enterprises of Pharmaceutical Industry;
国有医药企业合并后的品牌整合问题——以广州医药集团为例
2.
Problems and Methods of the Human Resource Management in the State-own Pharmaceutical Enterprises;
国有医药企业人力资源管理存在的问题及对策
3.
The Present Situation and Promoting Strategies of Informationlization of Pharmaceutical Enterprises in Our Country;
我国医药企业信息化现状与推进策略
4.
Discussion on Logistics Management of China s Pharmacy Chains;
我国医药零售连锁企业物流管理研究
5.
Development Strategies on Competitive Intelligence in Chinese Pharmaceutical Enterprises;
我国医药企业竞争情报发展策略浅析
6.
On the Countermeasures of the Development of Chinese Medicine Enterprises after China s Entering WTO;
加入WTO与我国医药企业发展对策研究
7.
The Research of Channel Relationship Management in Our Pharmaceutical Manufacturer
我国医药生产企业渠道关系管理研究
8.
The Analysis of the Relationship between the Social Responsibility and the Achievements of the Chinese Medical Enterprises;
我国医药企业社会责任与企业绩效关系探析
9.
Research of Enterprise Merger and Acquisition (M & A) and Medicine Industrial Structure Being Optimized;
企业并购与我国医药产业结构优化研究
10.
Development Strategies for Small and Medium-size Pharmaceutical Commercial Enterprises;
浅析我国中小型医药商业企业发展战略
11.
Comparative Study on Chinese and Foreign Medicine;
我国医药零售企业国际比较与对策研究
12.
The Study of the Sustainable Growth Strategy of Small and Medium-size Pharmaceutical Enterprises in Our Country;
我国中小型医药企业持续发展战略研究
13.
The Influence of Traditional Family Ethical Culture on Family Drug Business;
传统家族伦理文化对中国家族医药企业的影响
14.
Considering on Strategy of Medical Distribution Enterprise s Network Marketing;
中国医药流通企业网络营销策略的思考
15.
Application of E-commerce Business Model in the National Pharmaceutical Enterprises;
电子商务模式在我国医药企业中的应用
16.
On choices of innovation strategy of Chinese pharmaceutical enterprises from perspective of "Wise Pig Game";
从“智猪博弈”谈我国医药企业创新战略选择
17.
Using the game theory to analyze the small and medium-sized pharmaceutical enterprise’s optimal choice between innovation and imitation in China;
我国中小医药企业的创新与仿制的博弈分析
18.
To Analyse on Evolved Mechanism of Chinese Medicine Enterprises Active Innovation;
对我国医药企业自主创新演化机制的分析